CAPR insider transaction filings
CAPRICOR THERAPEUTICS, INC. — 30 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-29. Screen CAPR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 24,100 @ $3.18 · Sale (S): 24,100 @ $30.38 · Option exercise (M): 24,100 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Option exercise (M): 24,100 @ $3.18 · Sale (S): 24,100 @ $30.38 · Option exercise (M): 24,100 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 500 @ $3.18 · Sale (S): 500 @ $30 · Option exercise (M): 400 @ $3.18 · Sale (S): 400 @ $30 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Option exercise (M): 500 @ $3.18 · Sale (S): 500 @ $30 · Option exercise (M): 400 @ $3.18 · Sale (S): 400 @ $30 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Maurer Michael T — CHIEF COMMERCIAL OFFICER | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 3,000 @ $1.39 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Litvack Frank — Director | Option exercise (M): 3,937 @ $1.39 · Option exercise (M): 3,937 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 25,000 @ $3.18 · Sale (S): 25,000 @ $31.70 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Option exercise (M): 25,000 @ $3.18 · Sale (S): 25,000 @ $31.70 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Sabar Karimah Es — Director | Option exercise (M): 7,529 @ $3.18 · Sale (S): 7,529 @ $32 · Option exercise (M): 7,529 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Sabar Karimah Es — Director | Option exercise (M): 61,265 @ $4.86 · Sale (S): 61,265 @ $30.17 · Option exercise (M): 53,735 @ $4.86 · Sale (S): 53,735 @ $31.03 · Option exercise (M): 61,265 (derivative) @ $0 · Option exercise (M): 53,735 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 25,000 @ $3.18 · Sale (S): 25,000 @ $30.13 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Option exercise (M): 693 @ $1.39 · Option exercise (M): 21,488 @ $3.74 · Option exercise (M): 2,819 @ $3.18 · Sale (S): 25,000 @ $30.12 · Option exercise (M): 693 (derivative) @ $0 · Option exercise (M): 21,488 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-27 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Option exercise (M): 2,500 @ $1.39 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Kelliher Mike — Director | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Auwaerter Paul Gisbert — Director | Grant/award (A): 15,500 (derivative) @ $0 · Grant/award (A): 1,360 (derivative) @ $0 · Grant/award (A): 5,420 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Gotwals Philip J — Director | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Sabar Karimah Es — Director | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Krasney Karen — EVP, GENERAL COUNSEL | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Marban Linda — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Litvack Frank — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Musket David B — Director | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | DUNBAR GEORGE W JR — Director | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | DUNBAR GEORGE W JR — Director | Option exercise (M): 3,000 @ $1.39 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Marban Linda — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 25,000 @ $1.39 · Other (J): 12,500 @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Litvack Frank — Director | Option exercise (M): 25,000 @ $1.39 · Tax withholding (F): 2,543 @ $13.67 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | DUNBAR GEORGE W JR — Director | Option exercise (M): 750 @ $1.39 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Bergmann Anthony — CHIEF FINANCIAL OFFICER | Option exercise (M): 2,500 @ $1.39 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | COLLIER EARL M JR — Director | Option exercise (M): 750 @ $1.39 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
Recent 8-K events — CAPRICOR THERAPEUTICS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2026-06-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CAPR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →